IPO registrations (S-1, F-1) · Registrants

Monogram Biosciences, Inc.

SEC CIK
1094961 · filings on EDGAR ↗
Name on the registration
VIROLOGIC INC
Former names
VIROLOGIC INC (2000–2005)
Registration
Form S-1, first filed 2000-02-22, last 2000-05-01; 1 initial registration, 3 amendments
Outcome
Final prospectus filed 2000-05-02
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances 2835
Incorporated in
DE
Business address
345 OYSTER POINT BLVD., South San Francisco, CA 94080
EIN
94-3234479
EDGAR entity type
operating
Insiders and CEO pay
Monogram Biosciences, Inc. on the corporate pages

Offering terms

Final price
$7.00 per share (424B1 filed 2000-05-02, an initial public offering)
Shares sold
5,000,000
Gross proceeds
$35,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol VLGC
Lead underwriters
CIBC World Markets (2,180,000 shares); ING; Prudential Securities (1,090,000 shares); ING Barings LLC (1,090,000 shares)
Syndicate
Hambrecht & Quist (80,000); Wachovia (80,000); Cowen (80,000); UBS (80,000); Crowell, Weedon & Co (40,000); Roth Capital Partners (40,000); Dominick & Dominick LLC (40,000); Josephthal & Co. Inc (40,000); Leerink Partners (40,000); Parker/Hunter Incorporated (40,000); Stephens (40,000); First Security Van Kasper (40,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 5

FiledFormWhat it isName as filedEDGAR
2000-02-22S-1S-1 (registration)VIROLOGIC INC0000891618-00-001072 ↗
2000-03-27S-1/AS-1/A (amendment)VIROLOGIC INC0000936392-00-000152 ↗
2000-04-17S-1/AS-1/A (amendment)VIROLOGIC INC0000936392-00-000210 ↗
2000-05-01S-1/AS-1/A (amendment)VIROLOGIC INC0000936392-00-000225 ↗
2000-05-02424B1424B1 (final prospectus)VIROLOGIC INC0000936392-00-000233 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-05-01S-1/Aregistration statement$3.455,000,000$17,250,000Nasdaq VLGC3from the submission text; price line, shares headline, proceeds computed, cover names 3document ↗
2000-05-02424B1final prospectus$7.005,000,000$35,000,000Nasdaq VLGC16from the submission text; price sentence, shares general, proceeds table, underwriting table 15, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BARUCH THOMAS RDirector22006–2007
BATES MICHAEL POfficerVP Clinical Research; VP, Clinical Research52006–2009
BUI TIEN TOfficerVP Sales12006
DUNN MICHAEL JOHNOfficerChief Business Officer22006–2008
HIBBS KATHY LOfficerSr. VP, General Counsel; VP General Counsel; VP, General Counsel52006–2009
HITCHNER KENNETH NOfficerVP Pharm Collaborations; VP, Pharm Collaborations22006–2007
JENKINS WILLIAM JDirector42006–2009
JENNINGS EDMON RDirector42006–2009
KEPNER CRISTINADirector52006–2009
MENDLEIN JOHNDirector42006–2009
MERRIWEATHER ALFRED GOfficerSr. VP, CFO; VP Finance & CFO; VP, Finance, CFO52006–2009
PERSING DAVID HDirector42006–2009
PETROPOULOS CHRISTOS JOfficerChief Scientific Officer; VP, Virolgy & Chief Scientific; VP Virology & Chief Scientific; VP,Virology & Chief Scientific62006–2009
WELCH WILLIAM JOfficerSenior VP, Chief Commercial; SVP & Chief Commercial Officer; SVP, Chief Commercial Officer52006–2009
WHITECOMB JEANNETTEOfficerVP of Operations; VP Operations; VP, Operations72006–2009
YOUNG WILLIAM DDirector,OfficerChairman and CEO; Chairman & CEO; Chairman, CEO62006–2009
Wray PatriciaOfficerVice President Human Resources; VP, Human Resources52006–2009
Parry GordonOfficerVP, Oncology Research & Dvlp.; VP, R & D Oncology42008–2009
White Christine AnnaDirector32008–2009
SIEBEL KENNETH FTenPercentOwner322008–2009
LABORATORY CORP OF AMERICA HOLDINGSTenPercentOwner22009

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationMONOGRAM BIOSCIENCES, INC.NCState business registriesEIN (EXACT, as the state registration reports it)
ContractorMONOGRAM BIOSCIENCES INCCANonprofit contractors (Form 990)name and state
Federal award recipientMONOGRAM BIOSCIENCES INCCAFederal spending (USAspending)name and state
Federal award recipientMONOGRAM BIOSCIENCES, INC.CAFederal spending (USAspending)name and state
Patent assigneeMonogram Biosciences, Inc.CAPatents (USPTO)name and state
SEC filerMonogram Biosciences, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerMONOGRAM BIOSCIENCES, INC.CATrademarks (USPTO)name and state
Form 5500 plan sponsorMONOGRAM BIOSCIENCES, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry In Vitro & In Vivo Diagnostic Substances, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: In Vitro & In Vivo Diagnostic Substances · Health